Data showed positive unique and cell-specific effects on cellular membrane structure, mitochondrial function, oxidative stress, and viral infection protection.
Company's multiplexed platform pairs advanced molecular assays with cloud-enabled data analytics for real-time disease, pathogen and contaminant detection.
The trial is being conducted under the first investigational device exemption awarded to a company assessing a permanently implanted brain-computer interface.